OncLive® On Air
OncLive® On Air

OncLive® On Air

      |      

Prenumeranter

   Senaste videorna

FDA Approval Insights: Elranatamab in Relapsed/Refractory Multiple Myeloma
18:34
Fonkoua Sheds Light on Liver Cancer Clinical Trial Disparities
15:32
FDA Approval Insights: Talquetamab in Relapsed/Refractory Multiple Myeloma
15:27
Usmani Highlights the Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
14:57
Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC
14:06
Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST
21:55
FDA Approval Insights: Dostarlimab Plus Chemotherapy in dMMR/MSI-H Advanced Endometrial Cancer
11:53
FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML
10:45
Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
13:41
Sanai Spotlights Meningioma Symptoms, Treatment Options, and Research Needs
20:01
Danish Discusses the Benefits of SCINTIX Biology-Guided Radiotherapy in Metastatic Lung and Bone Cancers
14:48
Trent Talks Through Potential Clinical Applications and Future Directions for MRD in GIST
10:42
Camidge and Abbott Discuss the Role of the Biotechnology Analyst in Drug Development
42:33
Lunning and Kamdar Debate the Role of Pola-R-CHP in Treatment-Naïve DLBCL
20:34
Khan and Kwendakwema Discuss Financial Toxicity in Patients With Cancer
12:03
Lunning and Abramson Spotlight Developments and Challenges in LBCL Research and Management
32:13
FDA Approval Insights: Avapritinib in Indolent Systemic Mastocytosis
13:53
Kremyanskaya Highlights the Benefits of BET Inhibitors in Myelofibrosis
12:58
Short Shares Post-Conference Perspectives in Acute Lymphoblastic Leukemia From ASCO and EHA 2023
13:49
Camidge and Cetnar Revisit ASCO 2023 Data in Lung Cancer
50:05
Visa mer